financetom
Business
financetom
/
Business
/
Madrigal Pharmaceuticals Insider Sold Shares Worth $2,832,335, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Madrigal Pharmaceuticals Insider Sold Shares Worth $2,832,335, According to a Recent SEC Filing
Apr 4, 2024 7:00 AM

09:15 AM EDT, 04/04/2024 (MT Newswires) -- Richard S Levy, Director, on April 01, 2024, sold 11,000 shares in Madrigal Pharmaceuticals ( MDGL ) for $2,832,335. Following the Form 4 filing with the SEC, Levy has control over a total of 10,298 shares of the company, with 10,298 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1157601/000095017024041528/xslF345X03/ownership.xml

Price: 246.25, Change: +1.02, Percent Change: +0.42

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Quantum Biopharma Confirms No Safety, Tolerability Concerns in Phase 1 Lucid-MS Dosing Trial
Quantum Biopharma Confirms No Safety, Tolerability Concerns in Phase 1 Lucid-MS Dosing Trial
Aug 5, 2025
08:14 AM EDT, 08/05/2025 (MT Newswires) -- Quantum BioPharma ( QNTM ) on Tuesday said its Australian subsidiary has confirmed that no safety or tolerability concerns were identified in healthy participants following consecutive daily dosing of Quantum's lead candidate, Lucid-MS, in the Phase 1 trial. Lucid-MS is a patented new chemical entity (NCE) that has been shown in preclinical models...
Fox's Fiscal Q4 Adjusted Net Income, Revenue Rise
Fox's Fiscal Q4 Adjusted Net Income, Revenue Rise
Aug 5, 2025
08:13 AM EDT, 08/05/2025 (MT Newswires) -- Fox (FOX) reported fiscal Q4 adjusted net income Tuesday of $1.27 per share, up from $0.90 a year earlier. Analysts polled by FactSet expected $0.99. Revenue for the quarter ended June 30 was $3.29 billion, up from $3.09 billion a year earlier. Analysts surveyed by FactSet expected $3.12 billion. The company's shares were...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Biotech firm Curis Q2 revenue rises to $2.7 mln
Biotech firm Curis Q2 revenue rises to $2.7 mln
Aug 5, 2025
Overview * Curis ( CRIS ) Q2 revenue rises to $2.7 mln, beating analyst expectations * Net loss for Q2 narrows to $8.6 mln, exceeding analyst estimates * Adjusted EPS for Q2 beats expectations, reflecting improved financial performance Outlook * Curis ( CRIS ) expects to begin enrollment for CLL study later this year * Company plans head-to-head trial against...
Copyright 2023-2026 - www.financetom.com All Rights Reserved